NZ202891A - 2-oxo-1-aminocarbonylaminosulphonylaminocarbonyl azetidinones - Google Patents

2-oxo-1-aminocarbonylaminosulphonylaminocarbonyl azetidinones

Info

Publication number
NZ202891A
NZ202891A NZ202891A NZ20289182A NZ202891A NZ 202891 A NZ202891 A NZ 202891A NZ 202891 A NZ202891 A NZ 202891A NZ 20289182 A NZ20289182 A NZ 20289182A NZ 202891 A NZ202891 A NZ 202891A
Authority
NZ
New Zealand
Prior art keywords
amino
oxo
carbonyl
hydrogen
sulfonyl
Prior art date
Application number
NZ202891A
Other languages
English (en)
Inventor
H Breuer
T Denzel
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NZ202891A publication Critical patent/NZ202891A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NZ202891A 1982-01-04 1982-12-22 2-oxo-1-aminocarbonylaminosulphonylaminocarbonyl azetidinones NZ202891A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33653782A 1982-01-04 1982-01-04
US36860982A 1982-04-15 1982-04-15

Publications (1)

Publication Number Publication Date
NZ202891A true NZ202891A (en) 1986-02-21

Family

ID=26990250

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ202891A NZ202891A (en) 1982-01-04 1982-12-22 2-oxo-1-aminocarbonylaminosulphonylaminocarbonyl azetidinones

Country Status (19)

Country Link
EP (1) EP0085291B1 (Direct)
JP (1) JPS58121269A (Direct)
KR (1) KR890000418B1 (Direct)
AU (1) AU570912B2 (Direct)
CA (1) CA1272726C (Direct)
DD (1) DD207907A5 (Direct)
DE (1) DE3377712D1 (Direct)
DK (1) DK583A (Direct)
ES (1) ES8403108A1 (Direct)
FI (1) FI830017A7 (Direct)
GR (1) GR77135B (Direct)
HU (1) HU188986B (Direct)
IE (1) IE54388B1 (Direct)
IL (1) IL67528A (Direct)
NO (1) NO830003L (Direct)
NZ (1) NZ202891A (Direct)
PH (1) PH21695A (Direct)
PT (1) PT76064A (Direct)
SU (1) SU1391496A3 (Direct)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
KR880701238A (ko) * 1986-05-23 1988-07-26 로버트 에이 아르미티즈 N-1 치환 설포닐아미노카르보닐,c-4 치환 모노박탐
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
JPH02502455A (ja) * 1987-02-27 1990-08-09 ジ・アップジョン・カンパニー ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0344707A3 (en) * 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
KR20040044920A (ko) * 2001-09-14 2004-05-31 아벤티스 파마슈티칼스 인크. 카뎁신 억제제로서 신규한 화합물 및 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines

Also Published As

Publication number Publication date
FI830017L (fi) 1983-07-05
PH21695A (en) 1988-01-13
GR77135B (Direct) 1984-09-07
ES518758A0 (es) 1984-03-01
IE54388B1 (en) 1989-09-13
DK583A (da) 1983-07-05
AU570912B2 (en) 1988-03-31
AU9161782A (en) 1983-07-14
EP0085291B1 (en) 1988-08-17
IE823087L (en) 1983-07-04
HU188986B (en) 1986-05-28
DE3377712D1 (de) 1988-09-22
EP0085291A1 (en) 1983-08-10
KR890000418B1 (ko) 1989-03-17
IL67528A (en) 1986-04-29
ES8403108A1 (es) 1984-03-01
KR840002808A (ko) 1984-07-21
NO830003L (no) 1983-07-05
SU1391496A3 (ru) 1988-04-23
PT76064A (en) 1983-02-01
JPS58121269A (ja) 1983-07-19
CA1272726C (en) 1990-08-14
DK583D0 (da) 1983-01-03
FI830017A0 (fi) 1983-01-04
FI830017A7 (fi) 1983-07-05
CA1260472A (en) 1989-09-26
DD207907A5 (de) 1984-03-21

Similar Documents

Publication Publication Date Title
US4576749A (en) 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
EP0051381B1 (en) O-sulfated beta-lactam hydroxamic acids
CA1246572A (en) 2-oxo-1-[[(substituted sulfonyl)amino]- carbonyl]azetidines
NZ202891A (en) 2-oxo-1-aminocarbonylaminosulphonylaminocarbonyl azetidinones
IE55839B1 (en) Azetidine compounds
US4670553A (en) 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
EP0251143B1 (en) 2-Oxo-1-[[(Substituted Sulfonyl)Amino]-Carbonyl]Azetidines
US4559335A (en) 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
CA1198433A (en) (s)-[1-(carbonylaminosulfonyl)-2-oxo-3- azetidinyl]-carbamic acid
US4959470A (en) 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
NZ205642A (en) Beta-lactams and pharmaceutical compositions
CA1323368C (en) 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines
JPS6056989A (ja) β−ラクタム抗バクテリア剤
CA1272726A (en) 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4889930A (en) Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein
US4734496A (en) 4-amino derivatives of 2-oxo-1-azetidinesulfonic acid salts
FR2617483A1 (fr) 2-oxo-1-(((sulfonyl substitue)amino)-carbonyl)azetidines a action therapeutique
CA1254218A (en) 4-(3-acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
US5106977A (en) Intermediates for a process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl]azetidines
US4912214A (en) Isothiazolyl beta-lactam antibacterial agents
US4980465A (en) Process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl)] azetidines and intermediates used therein
US5068331A (en) Certain (2-carboxy or 2-propenoic or 2-carbonyl)-3-halo-4,5-dioxy pyridine intermediates and the corresponding 1,4-dihydro-4-pyridones)
CA1193272A (en) O-sulfated beta-lactam hydroxamic acids
CA1243679A (en) 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES
CA1268763A (en) 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters